François Potus

4.4k total citations
75 papers, 2.6k citations indexed

About

François Potus is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, François Potus has authored 75 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 32 papers in Molecular Biology and 26 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in François Potus's work include Pulmonary Hypertension Research and Treatments (60 papers), Cardiovascular Function and Risk Factors (15 papers) and MicroRNA in disease regulation (10 papers). François Potus is often cited by papers focused on Pulmonary Hypertension Research and Treatments (60 papers), Cardiovascular Function and Risk Factors (15 papers) and MicroRNA in disease regulation (10 papers). François Potus collaborates with scholars based in Canada, United States and United Kingdom. François Potus's co-authors include Sébastien Bonnet, Steeve Provencher, Sandra Breuils‐Bonnet, Stephen L. Archer, Ève Tremblay, Roxane Paulin, Olivier Boucherat, Danchen Wu, Asish Dasgupta and Jolyane Meloche and has published in prestigious journals such as Circulation, Circulation Research and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

François Potus

73 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Potus Canada 28 1.6k 1.2k 770 591 258 75 2.6k
Vinicio A. de Jesús Pérez United States 27 1.5k 0.9× 738 0.6× 699 0.9× 296 0.5× 308 1.2× 52 2.3k
Baktybek Kojonazarov Germany 24 1.5k 0.9× 840 0.7× 787 1.0× 356 0.6× 238 0.9× 63 2.3k
Jose Gomez‐Arroyo United States 24 1.6k 1.0× 548 0.5× 820 1.1× 274 0.5× 292 1.1× 45 2.0k
Shiro Mizuno Japan 23 1.5k 0.9× 582 0.5× 685 0.9× 338 0.6× 263 1.0× 70 2.1k
Anthony E. Dear Australia 25 629 0.4× 1.0k 0.8× 432 0.6× 171 0.3× 495 1.9× 51 2.3k
Ly Tu France 35 3.3k 2.0× 1.1k 0.9× 1.4k 1.8× 360 0.6× 631 2.4× 107 4.3k
Danchen Wu Canada 20 739 0.5× 856 0.7× 342 0.4× 272 0.5× 143 0.6× 31 1.6k
Jeffrey Mewburn Canada 24 643 0.4× 850 0.7× 374 0.5× 224 0.4× 159 0.6× 53 2.0k
Yongfeng Shao China 21 390 0.2× 602 0.5× 464 0.6× 249 0.4× 265 1.0× 114 1.5k
Xue‐Hai Zhu China 22 525 0.3× 973 0.8× 313 0.4× 445 0.8× 193 0.7× 43 1.7k

Countries citing papers authored by François Potus

Since Specialization
Citations

This map shows the geographic impact of François Potus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Potus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Potus more than expected).

Fields of papers citing papers by François Potus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Potus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Potus. The network helps show where François Potus may publish in the future.

Co-authorship network of co-authors of François Potus

This figure shows the co-authorship network connecting the top 25 collaborators of François Potus. A scholar is included among the top collaborators of François Potus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Potus. François Potus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Jinglin, Steeve Provencher, Sébastien Bonnet, et al.. (2025). Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges. Journal of Translational Medicine. 23(1). 1288–1288.
2.
Yokokawa, Tetsuro, Olivier Boucherat, Sandra Martineau, et al.. (2024). Prognostic Significance of Proteomics‐Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension. Journal of the American Heart Association. 13(12). e032888–e032888. 6 indexed citations
3.
Martineau, Sandra, Tsukasa Shimauchi, Sandra Breuils‐Bonnet, et al.. (2024). Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 209(11). 1376–1391. 7 indexed citations
4.
Provencher, Steeve, et al.. (2023). The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets. Vascular Pharmacology. 151. 107180–107180. 2 indexed citations
5.
Bourgeois, Alice, Tetsuro Yokokawa, Sandra Breuils‐Bonnet, et al.. (2023). G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 68(5). 537–550. 4 indexed citations
6.
Al‐Qazazi, Ruaa, Patrícia Lima, Sasha Z. Prisco, et al.. (2022). Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 206(5). 608–624. 98 indexed citations
7.
Hindmarch, Charles C.T., Lian Tian, François Potus, et al.. (2022). An integrated proteomic and transcriptomic signature of the failing right ventricle in monocrotaline induced pulmonary arterial hypertension in male rats. Frontiers in Physiology. 13. 966454–966454. 6 indexed citations
8.
Shimauchi, Tsukasa, Olivier Boucherat, Tetsuro Yokokawa, et al.. (2022). PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension. JACC Basic to Translational Science. 7(4). 384–403. 26 indexed citations
9.
Wu, Wenhui, Karima Habbout, Sandra Breuils‐Bonnet, et al.. (2021). R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models. European Respiratory Journal. 57(5). 2003271–2003271. 7 indexed citations
10.
Malenfant, Simon, Marius Lebret, François Potus, et al.. (2021). Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms. European Respiratory Review. 30(160). 200284–200284. 31 indexed citations
11.
Vitry, Géraldine, Roxane Paulin, Marie-Claude Lampron, et al.. (2020). Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 203(5). 614–627. 25 indexed citations
12.
Dasgupta, Asish, Danchen Wu, Lian Tian, et al.. (2020). Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen‐Sensing, Metabolism, and Dynamics. Comprehensive physiology. 10(2). 713–765. 45 indexed citations
13.
Boucherat, Olivier, Alice Bourgeois, Valérie Nadeau, et al.. (2018). Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 198(1). 90–103. 79 indexed citations
14.
Hong, Zhigang, Asish Dasgupta, François Potus, et al.. (2016). MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype. American Journal of Respiratory and Critical Care Medicine. 195(4). 515–529. 136 indexed citations
15.
Meloche, Jolyane, François Potus, Benoît Ranchoux, et al.. (2015). miR-223 reverses experimental pulmonary arterial hypertension. American Journal of Physiology-Cell Physiology. 309(6). C363–C372. 102 indexed citations
16.
Potus, François, Grégoire Ruffenach, Abdellaziz Dahou, et al.. (2015). Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. 132(10). 932–943. 168 indexed citations
17.
Malenfant, Simon, François Potus, Vincent Mainguy, et al.. (2015). Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in Pulmonary Hypertension. Medicine & Science in Sports & Exercise. 47(11). 2273–2282. 53 indexed citations
18.
Potus, François, Simon Malenfant, Colin Graydon, et al.. (2014). Impaired Angiogenesis and Peripheral Muscle Microcirculation Loss Contribute to Exercise Intolerance in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 190(3). 318–328. 103 indexed citations
19.
Malenfant, Simon, François Potus, Frédéric Fournier, et al.. (2014). Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension. Journal of Molecular Medicine. 93(5). 573–584. 59 indexed citations
20.
Meloche, Jolyane, Aude Pflieger, Mylène Vaillancourt, et al.. (2013). Role for DNA Damage Signaling in Pulmonary Arterial Hypertension. Circulation. 129(7). 786–797. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinicio A. de Jesús Pérez Breakdown of academic impact, for papers by Baktybek Kojonazarov Breakdown of academic impact, for papers by Jose Gomez‐Arroyo Breakdown of academic impact, for papers by Shiro Mizuno Breakdown of academic impact, for papers by Anthony E. Dear Breakdown of academic impact, for papers by Ly Tu Breakdown of academic impact, for papers by Danchen Wu Breakdown of academic impact, for papers by Jeffrey Mewburn Breakdown of academic impact, for papers by Yongfeng Shao Breakdown of academic impact, for papers by Xue‐Hai Zhu
Rankless by CCL
2026